Transfection Reagent And Equipment Market Will Cross $1.09Bn By 2022: Grand View Research, Inc.
The
global transfection reagent & equipment market is
expected to reach USD 1,086.02 million by 2022, according to a new report by
Grand View Research, Inc. This anticipated growth in demand can be attributed
to growing need for protein production, biopharmaceutical development, and
vaccine research and development; all of which rely heavily on cytological
R&D and transfection.
U.S. Transfection Reagent & Equipment Market revenue by method, 2012-2022, (USD Million) |
Larger
market entities are also involved in efforts to expand their market presence in
the Asia Pacific region and tap the high potential for growth available.
Expected growth of genomic and proteomic research is also a strong factor which
will positively impact the growth in demand for transfection.
Browse full
research report on Transfection Reagent And Equipment Market: www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market
Further key
findings from the report suggest:
- Out of
both the broad segments of products available, transfection equipment
accounted for a larger share of the market in 2014 and owing to their
inherently more expensive nature than reagents are expected to maintain
this dominant position over the forecast period.
- The
market space for transfection has an abundant number of methods to achieve
the aforementioned. However, these vary significantly in usage rates and
implementation complexities. Electroporation and liposomal transfection
combine to account for over 30% of the market owing to high associated
advantages.
- Growing
applications of transfection techniques poise the segments in a strong
position and estimated valuation clocks usage of transfection in gene
expression at over USD 130 million and for protein production at over USD
110 million for the year 2014.
- North
America was observed to be responsible for the largest share of revenue in
2014 which amounted to a little over USD 240 million. The United States
houses the headquarters of operations for a number of market leaders and a
number of established research and development. This provides a strong
platform for development, manufacture & distribution various vaccines,
and biopharmaceuticals which fuels market growth.
- However,
it is Asia Pacific region which is anticipated to witness significant
growth over the forecast period in various segments owing to considerable
growth of cytological research, development of biosimilar drugs and high
potential of growth in these relatively untapped regional segments.
- Asia
Pacific is expected to grow at a significant rate over the forecast period
in terms of increasing production and development of vaccines, drugs, and
new biologics. Supportive government initiatives pertaining to increasing
investments by manufacturers and governments in biopharmaceutical
manufacturing and high untapped market opportunities are the important
factors accounting for the expected growth of market in this region over the
forecast period.
- Promega,
Roche and Thermo Fisher owned Life Technologies accounted for the largest
of revenue in 2014 and are involved in new product development for
expansion of their portfolios over the forecast period. Acquisition of
smaller players is also expected over the forecast period by larger
companies
- Key
market players in the Transfection Reagent & Equipment Market include
BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene
Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories
Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies
(Thermo Fisher), and Promega Corporation.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented Transfection Reagent & Equipment
Market on the basis of product, method, application, and region:
Global
Transfection reagents & equipment Product Outlook (Revenue, USD
Million, 2012 - 2022)
- Reagents
- Equipment
Global
Transfection reagents & equipment Method Outlook (Revenue, USD Million,
2012 - 2022)
- Electroporation
- Liposomes
- Particle
Bombardment
- Microinjection
- Adenoviral
vectors
- Direct
microinjection
- Calcium
phosphate
- DEAE-dextran
- Magnetic
beads
- Activated
Dendrimers
- Laserfection
Global
Transfection reagents & equipment Application Outlook (Revenue, USD
Million, 2012 - 2022)
- Gene
expression studies
- Protein
production
- Transgenic
delivery
- Cancer
research
- Biomedical
research
Transfection
reagents & equipment Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-transfection-reagent-equipment-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment